RxDoctor Payments Data

Cynthia Salgado

Nurse Practitioner · Saint Joseph, MINPI 1598309437

Payments from drug & device makers

$1,580in general payments, 2019–2025

Across 87 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$242
  • Johnson & Johnson$182
  • Astellas Pharma US Inc$144
  • AstraZeneca$109
  • Novo Nordisk$97
  • Lilly USA, LLC$87
  • plus $719 from 17 others

What the payments were for

  • Food & beverage$1,580100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,580 in reported general payments places this provider in the 85th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Medicare billing

Part B allowed, 2024
$75,164
Medicare patients
478
Services billed
1,334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ErleadaApalutamide12$178,153
XtandiEnzalutamide11$164,811
MyrbetriqMirabegron127$84,498
GemtesaVibegron118$80,979
OrgovyxRelugolix14$38,273
Tamsulosin Hcl618$13,993
Potassium Citrate ErPotassium Citrate42$7,655
Mirabegron ErMirabegron15$5,283
Finasteride346$4,275
Solifenacin Succinate86$3,097
Silodosin35$2,429
Oxybutynin Chloride ErOxybutynin Chloride69$1,952
Estradiol31$1,711
Terazosin Hcl43$1,509
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst57$1,201

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncXtandi, Myrbetriq$144$249,309138 claims
Johnson & JohnsonErleada$182$178,15312 claims
Sumitomo Pharma America, Inc.Gemtesa, Orgovyx$242$119,253132 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Saint Joseph

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →